Clinical Trial Update: Comparison of Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination in pMDI Form in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing fixed-dose combination inhaler of ipratropium/levosalbutamol versus free-dose combination in stable COPD patients; status cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• ipratropium / levosalbutamol fixed-dose combination (ipratropium; levosalbutamol)
• ipratropium and levosalbutamol (ipratropium; levosalbutamol)

Snippet

Sponsor: Neutec Ar-Ge San ve Tic A.Ş | Conditions: COPD | Phase 3 | Status: UNKNOWN